Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00585559 |
|
Recruitment Status :
Terminated
First Posted : January 3, 2008
Last Update Posted : January 3, 2024
|
Sponsor:
Vanderbilt University Medical Center
Collaborators:
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Information provided by (Responsible Party):
Matthew Fusco, Vanderbilt University Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | October 26, 2023 |
| Actual Study Completion Date : | October 26, 2023 |